5125292026-09-085125292026-09-082026-09-08512529VIYASH SCIENTIFIC LIMITEDVIYASHNOTLISTEDINE807F01027Updatefalse2026-09-0723:59:002026-06-082026-07-212026-09-08Acquisition (including agreement to acquire)In continuation of our earlier disclosures dated June 8, 2026 and July 21, 2026 (collectively referred to as the “Disclosures”) regarding the proposed acquisition of 100% shareholding in BioForLife Italia S.r.l., Milan, Italy by Alivira Animal Health Limited, Ireland, a step-down wholly owned subsidiary of Viyash Scientific Limited, we wish to inform you that the requisite approval in connection with the applicable Italian FDI / Golden Power regulations has been received from the relevant Italian authorities. Further, taking into account the remaining customary closing formalities and closing conditions, the expected timeline for completion of the transaction has been revised, and the transaction is now expected to be completed within two months from the date of this intimation.OthersIn continuation of our earlier disclosures dated June 8, 2026 and July 21, 2026 (collectively referred to as the “Disclosures”) regarding the proposed acquisition of 100% shareholding in BioForLife Italia S.r.l., Milan, Italy by Alivira Animal Health Limited, Ireland, a step-down wholly owned subsidiary of Viyash Scientific Limited, we wish to inform you that the requisite approval in connection with the applicable Italian FDI / Golden Power regulations has been received from the relevant Italian authorities. Further, taking into account the remaining customary closing formalities and closing conditions, the expected timeline for completion of the transaction has been revised, and the transaction is now expected to be completed within two months from the date of this intimation.